Monaco Asset Management SAM Takes $1.22 Million Position in Teleflex Incorporated $TFX

Monaco Asset Management SAM acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,000 shares of the medical technology company’s stock, valued at approximately $1,220,000.

Other institutional investors have also modified their holdings of the company. Banque Cantonale Vaudoise raised its position in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the last quarter. Hantz Financial Services Inc. raised its position in shares of Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Teleflex in the third quarter valued at approximately $35,000. V Square Quantitative Management LLC acquired a new position in shares of Teleflex in the fourth quarter valued at approximately $37,000. Finally, Sound Income Strategies LLC acquired a new position in shares of Teleflex in the fourth quarter valued at approximately $45,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Performance

NYSE:TFX opened at $128.81 on Monday. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The company has a market cap of $5.70 billion, a P/E ratio of -5.65, a P/E/G ratio of 0.96 and a beta of 0.82. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67. The firm’s 50 day moving average is $124.88 and its two-hundred day moving average is $117.43.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. Teleflex’s revenue was up 32.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts expect that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Analysts Set New Price Targets

TFX has been the subject of a number of analyst reports. Needham & Company LLC boosted their price objective on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Friday, March 27th. Raymond James Financial reissued an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Finally, Mizuho set a $140.00 price target on shares of Teleflex in a research report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $144.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.